Business and Finance Outlook: US Dollar, Oil Surplus, and Pharma Deals

US Dollar Performance and Outlook

• 💰 The US dollar ended the third quarter with a 1% gain against major rivals, though it is down 10% year-to-date.
• ⚠️ Dollar bears may become active again, particularly if a US government shutdown is prolonged.
• 💹 FX experts suggest the yen looks favorable, and the euro might reach the $1.20 milestone.

Economic Data and Corporate Earnings

• 🗓️ The upcoming week's US data calendar is light, suggesting minimal market disruption from a government shutdown.
• 🏦 The US Treasury will conduct a normal auction of notes and bonds.
• 📊 Early third-quarter results will be released by companies like Delta Airlines and Levi Strauss on Thursday.
• 🏦 The earnings season officially kicks off the following week with reports from major Wall Street banks.

Pharmaceutical Sector Developments

• 💊 Battered global pharmaceutical stocks received a boost from a deal between Pfizer and the US to reduce prescription drug prices for Medicaid.
• 🤝 This agreement, which includes tariff relief, is seen as a more benign approach compared to previous actions targeting high US medicine prices.
• 📈 Investors anticipate this deal may encourage more transactions within the sector.

Global Oil Market Dynamics

• 🛢️ Oil is facing pressure due to substantial global supplies that outpace demand.
• 📈 The International Energy Agency projects an implied surplus of over 3 million barrels per day by 2026.
• 📉 Crude oil prices are currently around $65 a barrel, roughly half their value from when Russia invaded Ukraine in 2022.